Alnylam welcomes you to Capella, the destination for updates on our progress in translating the science of RNAi toward innovative medicines.
August 20, 2014
We have been hosting a series of online “RNAi Roundtables” during July and August, at which Alnylam scientists and key clinical collaborators have been reviewing recent progress from several “Alnylam 5×15” programs and discussing the related disease areas.
Next RNAi Roundtable:
ALN-AS1 for the treatment of Hepatic Porphyrias
Thursday, August 21: 4:00 – 5:00 p.m. ET
- Rachel Meyers, Ph.D., Vice President, Research and RNAi Lead Development
- Moderator: Barry Greene, President and Chief Operating Officer
- Guest Speaker: Karl Anderson, M.D., FACP, Professor, Departments of Preventive Medicine and Community Health (Division of Human Nutrition) and Internal Medicine (Division of Gastroenterology), and Director, Porphyria Laboratory & Center at the University of Texas Medical Branch
To register and access the webcast for this event, please click here.